MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Panellists at Patient Community Day 2026, held at the conclusion of MSToronto2026, are shown in discussion on stage.

Patient Community Day at MSToronto2026

MStranslate
November 6, 2026
Community, ECTRIMS, Events, Research
The word Toronto is shown displayed in large lettering on the edge of what could be a town square in downtown Toronto.

The ECTRIMS Podcast at MSToronto2026

MStranslate
November 5, 2026
Conferences, ECTRIMS, Research
1 Comment
3D medical illustration of HIV virus cells.

Antiviral Reverses Disability in Mouse Model of MS

MStranslate
September 28, 2026
Research, Treatments
cognition

Assessing & Monitoring Cognition in MS

MStranslate
August 11, 2026
Cognition, Research
News

Potential Changes to MS Treatment Access in Australia

MStranslate
July 2, 2026
Treatments
food allergy

Food Allergies & Increased Disease Activity In MS

MStranslate
January 2, 2019
Basic Sciences, Diet, Lifestyle, Research
Recently, we featured a Facebook post that mentioned the results of two major US studies, including one that looked at the links between multiple sclerosis and food allergies (the other on asthma and MS can be...
asthma

Asthma More Common In People With MS

MStranslate
December 28, 2018
Basic Sciences, Research
1 Comment
Recently, we featured a Facebook post that mentioned the results of two major US studies, one of which looked at the links between multiple sclerosis and asthma.  This generated a huge reaction from our...
Facebook Live

Facebook Live: Funding Multiple Sclerosis Research

MStranslate
December 18, 2018
Community, Research
On December 12, 2018, Brett Drummond (our Co-Founder and Chief Science Communicator) held a Facebook Live event to explore the issue of how multiple sclerosis research is...
smell

The Nose Knows: Can Smell Be A Marker Of MS Progression?

MStranslate
December 6, 2018
Research
Research Summary: Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration WHAT? A research study investigating whether specific...
treatment decision

What influences the choice of treatment in MS?

MStranslate
November 28, 2018
Research, Treatments, Uncategorized
Research Summary: Understanding treatment decisions from the perspective of people with relapsing remitting multiple sclerosis: A critical interpretive synthesis The past decade has seen a number of new...
T Cell Therapy

EBV-Specific T Cell Therapy for Progressive MS

MStranslate
November 20, 2018
Epstein-Barr virus, Infection, Progressive MS, Research, Treatments
Research Summary: Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis Last week, during our Facebook Live Q&A, we discussed the potential role of Epstein-Barr Virus or EBV in...
Gut Microbiome

ECTRIMS 2018: The Gut Microbiome in MS

MStranslate
November 19, 2018
Conferences, ECTRIMS, Research
1 Comment
"It is intriguing...can you modulate the gut microbiome to improve outcomes in MS, such as reducing relapse rates? That would be a fabulous end goal!" - Prof Helen Tremlett. The potential role of the gut...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 3

MStranslate
October 18, 2018
Conferences, ECTRIMS, Research
1 Comment
This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 2

MStranslate
October 15, 2018
Conferences, ECTRIMS, Research
2 Comments
This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 1

MStranslate
October 11, 2018
Conferences, ECTRIMS, Research
2 Comments
This year, MStranslate has invested in travelling to the ECTRIMS Congress 2018, recognising it's the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
  1. 9
  2. 10
  3. 11
  4. 12
  5. 13
  6. 14
  7. 15

Recent Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Recent Comments

  • Patient Community Day at MSToronto2026 on The ECTRIMS Podcast at MSToronto2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026

Calendar

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Sep    

Archives

Categories

Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.